The pro-fibrotic effect of exogenous IL-33 in NASH pathology was confirmed by another study and correlated with an increased frequency of IL-13-expressing monocytes/macrophages. This evidence concerns the gene IL13 and metabolic dysfunction-associated steatohepatitis.